Diphtheria antitoxin
Clinical data | |
---|---|
Routes of use | IM, IV |
Defined daily dose | not established[1] |
External links | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Diphtheria antitoxin (DAT) is a medication made up of antibodies used in the treatment of diphtheria.[2][3] It is no longer recommended for prevention of diphtheria.[3][4] It is given by injection into a vein or muscle.[3]
Side effects are common.[4] They include serum sickness and allergic reactions including anaphylaxis.[3] Diphtheria antitoxin is made from the blood plasma of horses that have been immunized against diphtheria toxin.[2] It works by neutralizing the toxins produced by Corynebacterium diphtheriae.[2]
Diphtheria antitoxin was developed and came into medical use in the late 1800s.[5] It is on the World Health Organization's List of Essential Medicines.[6] In the United States it can be obtained from the Center for Disease Control.[2] It is not available in many countries including many in Europe as of 2008.[7]
Chemistry
It is a solution of concentrated proteins, chiefly globulins, containing antibodies obtained from the blood of horses that have been immunized against diphtheria toxin.[2]
Medical uses
Dosage
The defined daily dose is not established.[1]
References
- ↑ 1.0 1.1 "WHOCC - ATC/DDD Index". www.whocc.no. Archived from the original on 24 September 2020. Retrieved 14 September 2020.
- ↑ 2.0 2.1 2.2 2.3 2.4 "Our Formulary | Infectious Diseases Laboratories | CDC". www.cdc.gov. 22 September 2016. Archived from the original on 16 December 2016. Retrieved 9 December 2016.
- ↑ 3.0 3.1 3.2 3.3 World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. p. 397. hdl:10665/44053. ISBN 9789241547659.
- ↑ 4.0 4.1 British national formulary : BNF 69 (69 ed.). British Medical Association. 2015. p. 850. ISBN 9780857111562.
- ↑ Hau, Jann; Schapiro, Steven J.; Jr, Gerald L. Van Hoosier (2004). Handbook of Laboratory Animal Science, Second Edition: Animal Models. CRC Press. p. 6. ISBN 9781420039627. Archived from the original on 2017-09-23.
- ↑ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- ↑ Wagner, KS; Stickings, P; White, JM; Neal, S; Crowcroft, NS; Sesardic, D; Efstratiou, A (10 December 2009). "A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use". Vaccine. 28 (1): 14–20. doi:10.1016/j.vaccine.2009.09.094. PMID 19818425.
External links
Identifiers: |
|
---|
- Diphtheria Antitoxin at the US National Library of Medicine Medical Subject Headings (MeSH)
- Pages using duplicate arguments in template calls
- Infobox drug articles without a structure image
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Chemicals that do not have a ChemSpider ID assigned
- Diphtheria
- World Health Organization essential medicines